Global evolution of inflammatory bowel disease across epidemiologic stages
University of Calgary · Maidstone and Tunbridge Wells NHS Trust · +70 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
275
total citations
- FWCI
- 378.04
- Percentile
- 100%
- References
- 59
Citations per year
Authors
66Topics & keywords
Keywords
- Incidence (geometry)
- Demography
- Population
- Inflammatory bowel disease
- Disease
- Latin Americans
- Developed country
- Medicine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- AAmgen
- BSBristol-Myers Squibb
- IFImpact Fund
- ELEli Lilly and Company
- PPfizer
- AAstraZeneca
- GGlaxoSmithKline
- SSanofi
- GSGilead Sciences
- BBiogen
- CCelgene
- LMLeona M. and Harry B. Helmsley Charitable TrustAward: G-2108-04777
- DPDouglas Pharmaceuticals
- EPEA Pharma Co., Ltd.
- MMylan
- KKissei
- CCelltrion
- EEisai
- KIKarolinska Institutet
- APAstellas Pharma
- HFHospital for Sick Children
- TPTillotts Pharma
- MTMitsubishi Tanabe Pharma Corporation
- BHBausch Health
- HKHong Kong Government
- GGenentech
- CICanadian Institutes of Health ResearchAwards: 162393, PJT-162393
- NCNational Cancer Institute
- JPJanssen Pharmaceuticals
- CCilag